Molecule Details
| InChIKey | ATLYLVPZNWDJBW-KIHHCIJBSA-N |
|---|---|
| Canonical SMILES | NC(=O)c1cccc([C@H]2C[C@H]3CC[C@@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.45 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12013 |
|---|---|
| Drug Name | Axelopran |
| CAS Number | 949904-48-7 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Axelopran has been used in trials studying the treatment of OIC and Opioid-induced Constipation. |
Categories: Acids, Carbocyclic Alkaloids Amides Aza Compounds Azabicyclo Compounds Benzene Derivatives Benzoates Opioid Antagonists
Cross-references: CHEMBL3137313 ChemSpider: 31444004 PubChem:67156338 PubChem:347828331 Wikipedia: Axelopran
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P35372 | OPRM1 | Mu-type opioid receptor | modulator | targets |